Neurostimulation Devices Market

By Author: Aarti
Total Articles: 458
Comment this article

Neurostimulation Devices Market was USD 6.5 billion in 2017, and it is expected to grow at 20.18% CAGR from 2017 to 2024.

Global Neurostimulation Devices Market

Neurostimulation is the determined modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the nervous system in terms of electromagnetic methods.

The rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, migraine, chronic lower back pain, dementias, and epilepsy will drive the Global Neurostimulation Devices Market size. In addition to this, a rising elderly patient base across the globe is another major factor that drives the industry growth as the geriatric patient pool is more unguarded to neurological disorders fuelling demand for neurostimulators in the future.

Global Neurostimulation Devices Market is segmented by product, application, end user, region and geography. Global neurostimulation devices have the predominant usage in depression, dystonia, epilepsy, essential tremors, gastroparesis disorders, incontinence, obsessive compulsion ...
... disorders (ocd), pain, and Parkinson’s disease, thereby making it one of the most widely used devices segment in the world.

North America, especially the U.S. will lead the Global Neurostimulation Devices Market over the current forecast period. Increasing extensiveness of neurological disorders, unruptured brain aneurysm, and chronic lower back pain are a few other factors that will stimulate demand for Global Neurostimulation Devices Market.

The major players in the neurostimulation device market are Boston Scientific Corporation, Cyberonics Inc, St. Jude Medical Inc, Medtronic Inc., NeuroPace Inc., and NeuroSigma, Inc.

The years that have been considered for the study are:

• Base year – 2016
• Estimated year – 2017
• Forecast period – 2017 to 2026

Key Highlights:

• Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period
• Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities.
• Global Neurostimulation Devices Market analysis and comprehensive segmentation with respect to the Product, Technology, Application, and geography to assist in strategic business planning.
• Global Neurostimulation Devices Market analysis and forecast for five major geographies, North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions.

Research Methodology

The market is estimated by analyzing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of the market were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this analysis. This country-specific analysis was accumulated to establish regional numbers and then arrive at a global market value for Global Neurostimulation Market.

Key Players in the Global Neurostimulation Market Are:

• Nevro
• NeuroPace, Inc.
• MED-EL.
• Aleva Neurotherapeutics SA
• BioControl Medical
• Bioness Inc
• EnteroMedics Inc
• Nevro Corporation
• Autonomic Technologies
• Multi Radiance Medical, Inc
• Neuronetics, Inc
• American Imex
• Amrex Electrotherapy Equipment
• Electromedical Products International (EPI)

Market KEY Segment:

By Product:
• Spinal Cord Stimulator
• Deep Brain Stimulator
• Sacral Nerve Stimulator
• Vagus Nerve Stimulator
• Gastric Electric Stimulator

By Application:
• Pain Management
• Epilepsy
• Essential Tremor
• Urinary and Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's Disease

By Geography:
• North America
• Europe
• Asia Pacific
• Rest of World (Row)

By Region
North America
• US
• Canada

Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Rest of Asia Pacific

Rest of the World (RoW):
• Middle-East
• Africa
• Latin America

This Report Is Submitted By @Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact Us:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH
Email: sales@maximizemarketresearch.com
Contact: +91 9607365656